These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. ELISA-based evaluation of antibody response to Leishmania in a region endemic for cutaneous leishmaniasis. Piyasiri SB; Samaranayake TN; Silva H; Manamperi NH; Karunaweera ND Parasite Immunol; 2022 Sep; 44(9):e12940. PubMed ID: 35836368 [TBL] [Abstract][Full Text] [Related]
3. Validation of an In-House ELISA Method in the Diagnosis of Cutaneous Leishmaniasis Caused by De Silva NL; De Silva VNH; Deerasinghe ATH; Rathnapala UL; Kato H; Itoh M; Takagi H; Weerasooriya MV; Yahathugoda TC Microorganisms; 2022 Apr; 10(5):. PubMed ID: 35630365 [TBL] [Abstract][Full Text] [Related]
4. An Insight Into Systemic Immune Response in Thakur L; Madaan P; Jain A; Shankar V; Negi A; Chauhan SB; Sundar S; Singh OP; Jain M Front Immunol; 2021; 12():765684. PubMed ID: 35087516 [TBL] [Abstract][Full Text] [Related]
5. LmjF.36.3850, a novel hypothetical Leishmania major protein, contributes to the infection. Zutshi S; Sarode AY; Ghosh SK; Jha MK; Sudan R; Kumar S; Sadhale LP; Roy S; Saha B Immunology; 2021 Aug; 163(4):460-477. PubMed ID: 33764520 [TBL] [Abstract][Full Text] [Related]
6. Review on the Role of Host Immune Response in Protection and Immunopathogenesis during Cutaneous Leishmaniasis Infection. Dubie T; Mohammed Y J Immunol Res; 2020; 2020():2496713. PubMed ID: 32656269 [TBL] [Abstract][Full Text] [Related]
7. IgG1 as a potential biomarker of post-chemotherapeutic relapse in visceral leishmaniasis, and adaptation to a rapid diagnostic test. Bhattacharyya T; Ayandeh A; Falconar AK; Sundar S; El-Safi S; Gripenberg MA; Bowes DE; Thunissen C; Singh OP; Kumar R; Ahmed O; Eisa O; Saad A; Silva Pereira S; Boelaert M; Mertens P; Miles MA PLoS Negl Trop Dis; 2014 Oct; 8(10):e3273. PubMed ID: 25340782 [TBL] [Abstract][Full Text] [Related]
8. Vaccine Development Against Leishmania donovani. Das A; Ali N Front Immunol; 2012; 3():99. PubMed ID: 22615707 [TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and efficacy of single antigen Gp63, polytope and polytopeHSP70 DNA vaccines against visceral Leishmaniasis in experimental mouse model. Sachdeva R; Banerjea AC; Malla N; Dubey ML PLoS One; 2009 Dec; 4(12):e7880. PubMed ID: 19956549 [TBL] [Abstract][Full Text] [Related]
10. Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis. Saha S; Mazumdar T; Anam K; Ravindran R; Bairagi B; Saha B; Goswami R; Pramanik N; Guha SK; Kar S; Banerjee D; Ali N J Clin Microbiol; 2005 Mar; 43(3):1269-77. PubMed ID: 15750095 [TBL] [Abstract][Full Text] [Related]
11. Performance evaluation of serum IgG subclass quantification using a SPAPLUS turbidimetric analyzer and comparison with the BNII nephelometer. Cho EH; Choi R; Kang ES; Park HD Scand J Clin Lab Invest; 2018 Oct; 78(6):496-500. PubMed ID: 30261761 [TBL] [Abstract][Full Text] [Related]
12. IgG and IgG subclass antibodies in patients with active cutaneous leishmaniasis. Ozbılge H; Aksoy N; Gurel MS; Yazar S J Med Microbiol; 2006 Oct; 55(Pt 10):1329-1331. PubMed ID: 17005779 [TBL] [Abstract][Full Text] [Related]
13. Decrease in anti-Leishmania IgG3 and IgG1 after cutaneous leishmaniasis lesion healing is correlated with the time of clinical cure. Fagundes-Silva GA; Vieira-Goncalves R; Nepomuceno MP; de Souza MA; Favoreto S; Oliveira-Neto MP; Da-Cruz AM; Gomes-Silva A Parasite Immunol; 2012 Oct; 34(10):486-91. PubMed ID: 22742527 [TBL] [Abstract][Full Text] [Related]
14. [Immunoglobulin isotype and IgG subclass profiles in American tegumentary leishmaniasis]. de Souza MA; da Silva AG; Afonso-Cardoso SR; Favoreto SJ; Ferreira MS Rev Soc Bras Med Trop; 2005; 38(2):137-41. PubMed ID: 15821787 [TBL] [Abstract][Full Text] [Related]
15. Clinical value of anti-live Leishmania (Viannia) braziliensis immunoglobulin G subclasses, detected by flow cytometry, for diagnosing active localized cutaneous leishmaniasis. Rocha RD; Gontijo CM; Elói-Santos SM; Teixeira-Carvalho A; Corrêa-Oliveira R; Ferrari TC; Marques MJ; Mayrink W; Martins-Filho OA Trop Med Int Health; 2006 Feb; 11(2):156-66. PubMed ID: 16451339 [TBL] [Abstract][Full Text] [Related]